AMICUS THERAPEUTICS, INC. (FOLD)

Empfehlung

4,9
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)

Kritische 8-K Meldungen

Stammdaten

Unternehmen

NameAMICUS THERAPEUTICS, INC.
TickerFOLD
CIK0001178879

Branche

SIC-Code2834
BeschreibungPharmaceutical Preparations

Wertpapier

CUSIP
ISIN
TypCommon Stock
TitelAMICUS THERAPEUTICS, INC.

Status

Zuletzt geprüft2026-03-24 16:11:59.71984

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K634,210,000-27,110,000-0.09949,870,000274,241,000

Fondsaktivität (letzte 3 Quartale)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-03-02Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-22,50014.35-322,839.00-77,5%
2026-03-02Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-22,50014.35-322,839.00-77,5%
2026-01-20Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-75,00014.31-1,073,182.50-257,6%
2026-01-20Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-75,00014.31-1,073,182.50-257,6%
2025-12-19Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64214.17-363,380.47-87,2%
2025-12-19Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64214.17-363,380.47-87,2%
2025-12-15Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-77,92610.86-846,011.41-203,1%
2025-12-15Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-77,92610.86-846,011.41-203,1%
2025-12-15Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64311.00-282,073.00-67,7%
2025-12-15Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64311.00-282,073.00-67,7%
2025-12-01Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-14,58710.01-146,011.49-35,1%
2025-12-01Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-14,58710.01-146,011.49-35,1%
2025-11-26Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-23,62110.00-236,210.00-56,7%
2025-11-26Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-23,62110.00-236,210.00-56,7%
2025-11-25Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-36,00010.00-360,000.00-86,4%
2025-11-25Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-36,00010.00-360,000.00-86,4%
2025-11-24Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-36,00010.06-362,268.00-87,0%
2025-11-24Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-14,58710.04-146,522.04-35,2%
2025-11-24Campbell Bradley LDirector, Officer, President and CEOOpen Market Sale-14,58710.04-146,522.04-35,2%
2025-11-24Rosenberg EllenOfficer, Chief Legal OfficerOpen Market Sale-36,00010.06-362,268.00-87,0%
2025-11-24Castelli JeffOfficer, Chief Development OfficerOpen Market Sale-76,15810.16-773,658.66-185,7%
2025-11-24Castelli JeffOfficer, Chief Development OfficerOpen Market Sale-76,15810.16-773,658.66-185,7%
2025-11-24Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64310.10-258,932.76-62,2%
2025-11-24Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,64310.10-258,932.76-62,2%
2025-11-04Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,6439.51-243,859.80-58,5%
2025-11-04Clark David MichaelOfficer, Chief People OfficerOpen Market Sale-25,6439.51-243,859.80-58,5%

Top-Fondshalter (aktuelles Quartal)

Keine Fondsdaten für das aktuelle Quartal vorhanden.